Tevogen Bio

09/23/2025

📰 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞: https://www.globenewswire.com/news-release/2025/09/23/3154674/0/en/Tevogen-Highlights-Potential-Role-of-TVGN-489-in-Eliminating-Persistent-Viral-Reservoirs-Linked-to-Long-COVID.html

“These recent scientific reports strengthen the theory that Long COVID is, at least in part, sustained by a persistent viral reservoir,” said Dr. Ryan Saadi, Founder and CEO of Tevogen. “Our investigational therapy, TVGN 489, is uniquely designed to eliminate virus-infected cells. Tevogen is actively preparing for clinical manufacturing of TVGN 489 and while more research is needed, based on positive dose-finding trial data, I am highly optimistic that TVGN 489 has the potential to restore homeostasis in patients suffering from this debilitating condition.”

09/19/2025

📰 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞: https://globenewswire.com/news-release/2025/09/19/3153373/0/en/Tevogen-Commends-HHS-for-Addressing-Long-COVID-Emphasizes-TVGN-489-s-Potential-Impact-for-20-Million-Americans.html

“I have always prioritized SARS-CoV-2 and its lasting consequences. Long COVID has disrupted the lives of millions of patients and families, and I am highly optimistic that our investigational therapy, TVGN 489, could make a meaningful difference in restoring health and hope for these individuals.” - Dr. Ryan Saadi, Founder and CEO Tevogen


U.S. U.S. Department of Health and Human Services

03/12/2025

Thank you to Tapan from Tevogen Bio for visiting us at the Opportunity Project Clubhouse today to learn more about our programs and services. Member Davante was thrilled to give you a tour and tell you about his journey of recovery. We look forward to future collaborations.

02/07/2025

🎞 𝐓𝐞𝐯𝐨𝐠𝐞𝐧 𝐁𝐢𝐨'𝐬 𝐄𝐱𝐚𝐜𝐓𝐜𝐞𝐥𝐥 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 🎞
MoA and Development

02/07/2025

📰 Press Release: https://www.globenewswire.com/news-release/2025/02/07/3022978/0/en/Tevogen-Bio-Meets-BARDA-TechWatch-Team-Highlighting-ExacTcell-Technology-s-Potential-as-a-Scalable-Medical-Countermeasure.html

During the meeting, Tevogen Bio discussed ExacTcell’s unique ability to rapidly adapt to emerging viral threats, positioning it as a potential countermeasure to safeguard public health. Tevogen Bio will follow up with key federal entities and continue to update stakeholders.

▪ VITAL Biotech Accelerator Program

▪ Department of Defense - Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense

▪ Antivirals and Antitoxins Branch within BARDA’s Division of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

01/24/2025

📰 Press Release: https://www.globenewswire.com/news-release/2025/01/24/3015137/0/en/Tevogen-Bio-Broadens-Relationship-with-Microsoft-to-Deepen-Artificial-Intelligence-Collaboration-and-Develop-PredicTcell-Technology-on-Azure.html

“As we expand our AI efforts, this broader relationship with Microsoft represents a key milestone in our ongoing journey to revolutionize immunotherapy,” said Mittul Mehta, CIO of Tevogen Bio and Head of Tevogen.AI. “Through deeper collaboration with Microsoft domain experts, we will further harness the power of AI to bring more precise and personalized treatments to patients at an accelerated pace.”

12/23/2024

📰 Press Release: https://www.globenewswire.com/news-release/2024/12/23/3001305/0/en/Tevogen-Bio-to-Host-Panel-AI-In-Biopharma-Next-Frontier-of-Medical-Innovation-During-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html

Panelists will include Dr. David Rhew, Global Chief Medical Officer & VP of Healthcare of Microsoft , Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, and Sean Tunis, Principal of Rubix Health.

$TVGN

12/19/2024

📰 Press Release: https://lnkd.in/g49krfs5

“When combining our expertise across biopharma and artificial intelligence, we anticipate becoming a leader in the field with breakthroughs to follow,” said Tevogen Bio CEO Ryan Saadi, MD, MPH. “We will provide additional updates about the company, including our AI effort, at the J.P. Morgan Healthcare Conference in January 2025.”

12/10/2024

📰 Press Release: https://www.globenewswire.com/news-release/2024/12/10/2994925/0/en/Tevogen-Bio-to-Attend-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html

12/05/2024

📰Press Release: https://www.globenewswire.com/news-release/2024/12/05/2992527/0/en/Dr-Ryan-Saadi-Commends-Individuals-Who-Dedicate-Time-to-Public-Service-and-Congratulates-Mayor-Victor-Sordillo-on-His-Induction-Into-the-NJ-League-of-Municipalities-Hall-of-Fame.html

“It has been an honor to serve the residents of Warren and be part of a very high performing team of committee people. During our tenure, we built a new library, a new town hall, extensive youth facilities including the football complex, playgrounds, and basketball courts; and purchased around 1,000 acres of open space which includes the Wagner Farm. This was accomplished while maintaining a AAA bond rating and having one tenth of the long-term debt allowable by the State of NJ.” said Victor Sordillo

Warren Township, New Jersey New Jersey State League of Municipalities State of New Jersey
$TVGN

11/27/2024